Progress in the development of peroxide-based anti-parasitic agents

Drug Discovery Today

Volumn 14, Issue 15-16, 2009, Pages 793-803

  Muraleedharan, K M ^a   Avery, Mitchell A ^b  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^b Laboratory for Applied Drug Design and Synthesis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE DERIVATIVE; AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ANTIMALARIAL AGENT; ANTIPARASITIC AGENT; ARTEETHER; ARTEFLENE; ARTELINIC ACID; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTEMISONE; ARTESUNATE; ARTESUNATE PLUS CHLORPROGUANIL PLUS DAPSONE; ARTESUNATE PLUS FANSIDAR; ARTESUNATE PLUS MEFLOQUINE; ARTESUNATE PLUS PYRONARIDINE; BENFLUMETOL; CDA; CHLOROQUINE; DIHYDROARTEMISININ; FENOZAN B07; LAPDAP PLUS; MEFLOQUINE; NATURAL PRODUCT; OZ 277; PEROXIDE; PIPERAQUINE; PLACEBO; PRAZIQUANTEL; QUININE; RBX 11160; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIPROTOZOAL ACTIVITY; CHEMICAL MODIFICATION; CLINICAL TRIAL; DISEASE MODEL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG EFFICACY; DRUG HALF LIFE; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG RESEARCH; DRUG SAFETY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG TOLERABILITY; HUMAN; IN VITRO STUDY; LEISHMANIA; MALARIA; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM BERGHEI INFECTION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PROTOZOAL INFECTION; REVIEW; SCHISTOSOMIASIS; SINGLE DRUG DOSE; SKIN LEISHMANIASIS; STRUCTURE ACTIVITY RELATION; TOXOPLASMA; TRYPANOSOMA;

ANIMALS; ANTIPARASITIC AGENTS; ARTEMISININS; DRUG DESIGN; HUMANS; PARASITIC DISEASES; PEROXIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 67849084837     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2009.05.008     Document Type: Review

References (90)

1. Renslo A.R., and McKerrow J.H. Drug discovery and development for neglected parasitic diseases. Nat. Chem. Biol. 2 (2006) 701-710
2. Abu-Raddad L.J., et al. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 314 (2006) 1603-1606
3. Wolday D., et al. Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitol. Today 15 (1999) 182-187
4. Pacheco R.S., et al. Chagas' disease and HIV co-infection: genotypic characterization of the Trypanosoma cruzi strain. Memórias do Instituto Oswaldo Cruz 93 (1998) 165-169
5. O'Neill P.M., and Posner G.H. A medicinal chemistry perspective on artemisinin and related endoperoxides. J. Med. Chem. 47 (2004) 2945-2964
6. Jefford C.W. New developments in synthetic peroxidic drugs as artemisinin mimics. Drug Discov. Today 12 (2007) 487-495
7. Janse C.J., et al. Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model. Int. J. Parasitol. 24 (1994) 589-594
8. Balint G.A. Artemisinin and its derivatives: an important new class of antimalarial agents. Pharmacol. Ther. 90 (2001) 261-265
9. Guidelines for the treatment of malaria-a publication by World Health Organization (http://www.who.int/malaria/docs/TreatmentGuidelines2006.pdf)
10. Bukirwa H., et al. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin. Trials 1 (2006) e7
11. Danis M., and Bricaire F. The new drug combinations: their place in the treatment of uncomplicated Plasmodium falciparum malaria. Fundam. Clin. Pharmacol. 17 (2003) 155-160
12. Poole S., (text editor) (2001) The use of anti-malarial drugs-a report by WHO (http://rbm.who.int/cmc_upload/0/000/014/923/use_of_antimalarials.pdf)
13. Baker J.K., et al. Decomposition of arteether in simulated stomach acid yielding compounds retaining antimalarial activity. Pharm. Res. 10 (1993) 662-666
14. Brewer T.G., et al. Fatal neurotoxicity of arteether and artemether. Am. J. Trop. Med. Hyg. 51 (1994) 251-259
15. Brewer T.G., et al. Neurotoxicity in animals due to arteether and artemether. Trans. R. Soc. Trop. Med. Hyg. 88 Suppl. 1 (1994) 33-36
16. Gordi T., and Lepist E.-I. Artemisinin derivatives: toxic for laboratory animals, safe for humans?. Toxicol. Lett. 147 (2004) 99-107
17. Lin A.J., et al. Antimalarial activity of new water-soluble dihydroartemisinin derivatives. J. Med. Chem. 30 (1987) 2147-2150
18. Hartell, M.G. et al. (2003) Artemisinins with improved stability and bioavailability for therapeutic drug development and application. US patent applications 7084132 B2 and 6951846 B2
19. Information from 'Medicines for Malaria Venture' web site (http://www.mmv.org)
20. Haynes R.K., et al. Artemisone-a highly active antimalarial drug of the artemisinin class. Angew. Chem. 45 (2006) 2082-2088
21. Vivas L., et al. Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo. J. Antimicrob. Chemother. 59 (2007) 658-665
22. Nagelschmitz J., et al. First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone. Antimicrob. Agents Chemother. 52 (2008) 3085-3091
23. O'Neill P.M., et al. Synthesis, antimalarial activity, biomimetic iron(II) chemistry, and in vivo metabolism of novel, potent C-10-phenoxy derivatives of dihydroartemisinin. J. Med. Chem. 44 (2001) 58-68
24. Magueur G., et al. Fluoroartemisinin: trifluoromethyl analogues of artemether and artesunate. J. Med. Chem. 47 (2004) 2694-2699
25. Avery M.A., et al. Structure-activity relationships of the antimalarial agent artemisinin, 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies. J. Med. Chem. 45 (2002) 292-303 and references therein
26. Avery M.A., et al. Structure-activity relationships of the antimalarial agent artemisinin. 7. Direct modification of (+)-artemisinin and in vivo antimalarial screening of new, potential preclinical antimalarial candidates. J. Med. Chem. 45 (2002) 4321-4335
27. Grellepois F., et al. Orally active antimalarials: hydrolytically stable derivatives of 10-trifluoromethyl anhydrodihydroartemisinin. J. Med. Chem. 47 (2004) 1423-1433
28. Posner G.H., et al. Orally active, water-soluble antimalarial 3-aryltrioxanes: short synthesis and preclinical efficacy testing in rodents. J. Med. Chem. 45 (2002) 3824-3828
29. Avery M.A., et al. Structure-activity relationships of the antimalarial agent artemisinin, 2. Effect of heteroatom substitution at O-11: synthesis and bioassay of N-alkyl-11-aza-9-desmethylartemisinins. J. Med. Chem. 38 (1995) 5038-5044
30. Posner G.H., et al. Orally active antimalarial 3-substituted trioxanes: new synthetic methodology and biological evaluation. J. Med. Chem. 41 (1998) 940-951
31. Cumming J.N., et al. Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogs of the antimalarial artemisinin. J. Med. Chem. 41 (1998) 952-964
32. Avery M.A., et al. Synthesis, conformational analysis, and antimalarial activity of tricyclic analogs of artemisinin. Tetrahedron 50 (1994) 957-972
33. Posner G.H., et al. Malaria-infected mice are cured by a single dose of novel artemisinin derivatives. J. Med. Chem. 50 (2007) 2516-2519
34. Avery M.A., et al. Structure-activity relationships of the antimalarial agent artemisinin. 8. Design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria. J. Med. Chem. 46 (2003) 4244-4258
35. Parshikov I.A., et al. Hydroxylation of 10-deoxoartemisinin by Cunninghamella elegans. J. Nat. Prod. 67 (2004) 1595-1597
36. Parshikov I.A., et al. Transformation of artemisinin by Cunninghamella elegans. Appl. Microbiol. Biotechnol. 64 (2004) 782-786
37. Zhan J.-X., et al. Microbial metabolism of artemisinin by Mucor polymorphosporus and Aspergillus niger. J. Nat. Prod. 65 (2002) 1693-1695
38. Selmeczi K., et al. Alkylation of human hemoglobin A0 by the antimalarial drug artemisinin. FEBS Lett. 556 (2004) 245-248
39. Robert A., et al. From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs. Acc. Chem. Res. 35 (2002) 167-174
40. Haynes R.K., et al. Highly antimalaria-active artemisinin derivatives: biological activity does not correlate with chemical reactivity. Angew. Chem. 43 (2004) 1381-1385
41. Haynes R.K. Reply to comments on 'Highly antimalaria-active artemisinin derivatives: biological activity does not correlate with chemical reactivity'. Angew. Chem. 44 (2005) 2064-2065
42. Stocks P.A., et al. Evidence for a common non-heme chelatable-iron-dependent activation mechanism for semisynthetic and synthetic endoperoxide antimalarial drugs. Angew. Chem. 46 (2007) 6278-6283
43. Bhisutthibhan J., et al. The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. J. Biol. Chem. 273 (1998) 16192-16198
44. Kannan R., et al. Heme-artemisinin adducts are crucial mediators of the ability of artemisinin to inhibit heme polymerization. Chem. Biol. 9 (2002) 321-332
45. Wang D.-Y., and Wu Y.-L. A possible antimalarial action mode of qinghaosu (artemisinin) series compounds. Alkylation of reduced glutathione by C-centered primary radicals produced from antimalarial compound qinghaosu and 12-(2,4-dimethoxyphenyl)-12-deoxoqinghaosu. Chem. Commun. 22 (2000) 2193-2194
46. Eckstein-Ludwig U., et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature 424 (2003) 957-961
47. Robert A., et al. The antimalarial drug artemisinin alkylates heme in infected mice. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 13676-13680
48. Jambou R., et al. Resistance of Plasmodium falciparum field isolates to in vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 366 (2005) 1960-1963
49. Tang Y., et al. Synthetic peroxides as antimalarials. Med. Res. Rev. 24 (2004) 425-448
50. Jefford C.W. Why artemisinin and certain synthetic peroxides are potent antimalarials. Implications for the mode of action. Curr. Med. Chem. 8 (2001) 1803-1826
51. Peters W., et al. The chemotherapy of rodent malaria. XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 2: structure-activity studies on cis-fused cyclopenteno-1,2,4-trioxanes (fenozans) against drug-sensitive and drug-resistant lines of Plasmodium berghei and P. yoelii ssp. NS in vivo. Ann. Trop. Med. Parasitol. 87 (1993) 9-16
52. Tripathi R., et al. Evaluation of some adamantane-based synthetic trioxanes against Plasmodium knowlesi in rhesus monkeys. Life Sci. 81 (2007) 1544-1548
53. Hofheinz W., et al. Ro 42-1611 (arteflene), a new effective antimalarial: chemical structure and biological activity. Trop. Med. Parasitol. 45 (1994) 261-265
54. Bachi M.D., et al. A short synthesis and biological evaluation of potent and nontoxic antimalarial bridged bicyclic β-sulfonyl-endoperoxides. J. Med. Chem. 46 (2003) 2516-2533
55. O'Neill P.M., et al. Design and synthesis of endoperoxide antimalarial prodrug models. Angew. Chem. 43 (2004) 4193-4197
56. Vennerstrom J.L., et al. Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 430 (2004) 900-904
57. Vennerstrom, J.L. et al. (2005) Spiro and dispiro 1,2,4-trioxolane antimalarials, and their preparation, pharmaceutical compositions, and use in the treatment of malaria, cancer, and schistosomiasis. US patent applications: 6825230B2 (2004); 6486199 B1 (2002) and 6906205 B2
58. Snyder C., et al. In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models. Exp. Parasitol. 115 (2007) 296-300
59. Information from Ranbaxy's website (http://www.ranbaxy.com)
60. Press release in the web (http://www.bseindia.com/xml-data/corpfiling/announcement/Ranbaxy_Labora tories_Ltd_160908.pdf)
61. Dong Y. Synthesis and antimalarial activity of 1,2,4,5-tetraoxanes. Mini-Rev. Med. Chem. 2 (2002) 113-123
62. Kim H.-S., et al. Synthesis and antimalarial activity of cyclic peroxides, 1,2,4,5,7-pentoxocanes and 1,2,4,5-tetroxanes. J. Med. Chem. 42 (1999) 2604-2609
63. Kim H.-S., et al. Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes. J. Med. Chem. 44 (2001) 2357-2361
64. Sievänen E. Exploitation of bile acid transport systems in prodrug design. Molecules 12 (2007) 1859-1889
65. Opsenica D., et al. Cholic acid derivatives as 1,2,4,5-tetraoxane carriers: structure and antimalarial and antiproliferative activity. J. Med. Chem. 43 (2000) 3274-3282
66. Šolaja B.A., et al. Mixed steroidal 1,2,4,5-tetraoxanes: antimalarial and antimycobacterial activity. J. Med. Chem. 45 (2002) 3331-3336
67. Walsh J.J., et al. A novel artemisinin-quinine hybrid with potent antimalarial activity. Bioorg. Med. Chem. Lett. 17 (2007) 3599-3602
68. Loup C., et al. Trioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquine. Antimicrob. Agents Chemother. 51 (2007) 3768-3770
69. Dechy-Cabaret O., et al. Synthesis and antimalarial activity of trioxaquine derivatives. Chem. Eur. J. 10 (2004) 1625-1636
70. Yang D.M., and Liew F.Y. Effects of qinghaosu (artemisinin) and its derivatives on experimental cutaneous leishmaniasis. Parasitology 106 (1993) 7-11
71. Mishina Y.V., et al. Artemisinins inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense in vitro growth. Antimicrob. Agents Chemother. 51 (2007) 1852-1854
72. Menon R.B., et al. A new library of C-16 modified artemisinin analogs and evaluation of their anti-parasitic activities. Comb. Chem. High Throughput Screen. 9 (2006) 729-741
73. Sen R., et al. Artemisinin triggers induction of cell-cycle arrest and apoptosis in Leishmania donovani promastigotes. J. Med. Microbiol. 56 (2007) 1213-1218
74. Jones-Brando L., et al. In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin. Antimicrob. Agents Chemother. 50 (2006) 4206-4208
75. Ke O.Y., et al. Inhibition of growth of Toxoplasma gondii by qinghaosu and derivatives. Antimicrob. Agents Chemother. 34 (1990) 1961-1965
76. Chen D.J., et al. Chin. Med. J. 80 (1980) 422-428
77. Utzinger J., et al. Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites. Curr. Med. Chem. 8 (2001) 1841-1859
78. Utzinger J., et al. The potential of artemether for the control of schistosomiasis. Int. J. Parasitol. 31 (2001) 1549-1562
79. Lu S., et al. Evaluation of the anthelmintic effects of artesunate against experimental Schistosoma mansoni infection in mice using different treatment protocols. Parasitol. Int. 55 (2006) 63-68
80. Li Y.-S., et al. A double-blind field trial on the effects of artemether on Schistosoma japonicum infection in a highly endemic focus in southern China. Acta Tropica 96 (2005) 184-190
81. Ikuhiko N., et al. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. Int. J. Pharm. 354 (2008) 28-33
82. Posner G.H., et al. Anticancer activity of artemisinin-derived trioxanes. Expert Opin. Ther. Pat. 16 (2006) 1665-1672
83. Posner, G.H. et al. (2007) Trioxane dimers (artemisinin derivatives) having anticancer and antimalarial activities, processes for preparing them, and pharmaceutical compositions containing them. US patent application 6586464 B2
84. Macreadie P., et al. Novel endoperoxides: synthesis and activity against Candida species. Bioorg. Med. Chem. Lett. 16 (2006) 920-922
85. Galal A.M., et al. Antifungal activity of artemisinin derivatives. J. Nat. Prod. 68 (2005) 1274-1276
86. Casteel D.A. Peroxy natural products. Nat. Prod. Rep. 16 (1999) 55-73
87. Szpilman A.M., et al. Total syntheses of Yingzhaosu A and of its C(14)-epimer including the first evaluation of their antimalarial and cytotoxic activities. J. Org. Chem. 70 9 (2005) 3618-3632 see Liang, X. T. et al. (1979) Acta Chim. Sin., 37, 215-230 for details on its isolation
88. Takaya Y., et al. Novel antimalarial guaiane-type sesquiterpenoids from Nardostachys chinensis roots. Tetrahedron Lett. 39 (1998) 1361-1364
89. Takaya Y., et al. Novel Guaiane endoperoxides, Nardoguaianone A-D, from Nardostachys chinensis roots and their antinociceptive and antimalarial activities. Tetrahedron 56 (2000) 7673-7678
90. Kamchonwongpaisan S., et al. An antimalarial peroxide from Amomum krervanh Pierre. Tetrahedron Lett. 36 (1995) 1821-1824